|
US3520872A
(en)
|
1967-03-24 |
1970-07-21 |
Upjohn Co |
Process for labelling purine and pyrimidine containing compounds
|
|
US4792620A
(en)
|
1983-10-14 |
1988-12-20 |
Bp Chemicals Limited |
Carbonylation catalysts
|
|
IT1205043B
(it)
|
1987-05-28 |
1989-03-10 |
Innova Di Ridolfi Flora & C S |
Procedimento per l'estrazione di esteri di acidi grassi poliinsaturi da olii di pesce e composizioni farmaceutiche e dietetiche contenenti detti esteri
|
|
US5340742A
(en)
|
1988-09-07 |
1994-08-23 |
Omegatech Inc. |
Process for growing thraustochytrium and schizochytrium using non-chloride salts to produce a microfloral biomass having omega-3-highly unsaturated fatty acids
|
|
AU620929B2
(en)
|
1988-10-27 |
1992-02-27 |
Bar-Ilan University |
Method and compositions for treating alzheimer's disease, related dementias and epilepsy
|
|
DK0455783T3
(da)
|
1989-11-30 |
1996-04-01 |
Croda Int Plc |
Anvendelse af nervonsyre og langkædede fedtsyrer til behandlingen af demyeliniserende sygdomme
|
|
ES2033193B1
(es)
|
1990-10-30 |
1994-01-16 |
Ganadera Union Ind Agro |
Mezcla grasa para nutricion infantil y de adultos.
|
|
EP0567653A4
(en)
|
1991-11-14 |
1994-06-01 |
Sagami Chem Res |
Drug for hepatic diseases
|
|
JPH05246938A
(ja)
|
1992-02-19 |
1993-09-24 |
Sagami Chem Res Center |
重水素標識高級脂肪酸
|
|
CN1152316A
(zh)
|
1994-05-19 |
1997-06-18 |
麦克公司 |
具有烯丙基的甾族化合物的氧化
|
|
FR2721518B3
(fr)
|
1994-06-28 |
1996-04-12 |
Gattefosse Ets Sa |
Compositions cosmétiques, pharmaceutiques, diététiques, vétérinaires contenant de l'eau.
|
|
FR2722410B1
(fr)
|
1994-07-15 |
1996-10-04 |
Grinda Jean Robert |
Procede de stabilisation des acides gras poly-insatures et utilisation de ces produits stabilises entherapeutique
|
|
GB9423625D0
(en)
|
1994-11-23 |
1995-01-11 |
Scotia Holdings Plc |
Fortified fruit juice
|
|
JPH08268885A
(ja)
|
1995-03-30 |
1996-10-15 |
Oyo Seikagaku Kenkyusho |
過酸化脂質増量抑制剤
|
|
US5578334A
(en)
|
1995-04-07 |
1996-11-26 |
Brandeis University |
Increasing the HDL level and the HDL/LDL ratio in human serum with fat blends
|
|
CN1114878A
(zh)
|
1995-06-09 |
1996-01-17 |
郑州铁路局中心医院 |
一种防治心血管系统疾病的制剂
|
|
JPH0950274A
(ja)
|
1995-08-07 |
1997-02-18 |
Kawai Musical Instr Mfg Co Ltd |
アップライトピアノのフレーム
|
|
JPH09143492A
(ja)
|
1995-11-17 |
1997-06-03 |
Katsumasa Koike |
酸化脂質の確認方法及び酸化脂質の生成方法
|
|
JPH10291955A
(ja)
|
1997-04-22 |
1998-11-04 |
Sagami Chem Res Center |
１３ｃ標識ドコサヘキサエン酸及びその製造方法
|
|
JPH1070439A
(ja)
|
1996-08-29 |
1998-03-10 |
Hitachi Ltd |
受信装置
|
|
US20030013772A1
(en)
|
2000-02-23 |
2003-01-16 |
Murphy Michael A. |
Composition, synthesis and therapeutic applications of polyamines
|
|
US6111066A
(en)
|
1997-09-02 |
2000-08-29 |
Martek Biosciences Corporation |
Peptidic molecules which have been isotopically substituted with 13 C, 15 N and 2 H in the backbone but not in the sidechains
|
|
DE69832984T2
(de)
|
1997-10-08 |
2006-09-21 |
Isotechnika, Inc., Edmonton |
DEUTERIERtE und undeuterierte CYCLOSPORIN-ANALOGA UND IHRE VERWENDUNG ALS IMMUNMODULIERENDE AGENtIEN
|
|
US6270974B1
(en)
|
1998-03-13 |
2001-08-07 |
Promega Corporation |
Exogenous nucleic acid detection
|
|
US6468802B1
(en)
|
1998-05-06 |
2002-10-22 |
Isotechnika, Inc. |
13C glucose breath test for the diagnosis of diabetic indications and monitoring glycemic control
|
|
CN1326344A
(zh)
|
1998-10-15 |
2001-12-12 |
Dsm公司 |
Pufa增补剂
|
|
IT1304406B1
(it)
|
1998-10-21 |
2001-03-19 |
Danital Italia S R L |
Preparazione per la veicolazione di principi attivi basata su acidigrassi polinsaturi del gruppo omega 3.
|
|
US6503478B2
(en)
|
1999-01-13 |
2003-01-07 |
Lightouch Medical, Inc. |
Chemically specific imaging of tissue
|
|
US7271315B2
(en)
|
1999-01-14 |
2007-09-18 |
Martek Biosciences Corporation |
PUFA polyketide synthase systems and uses thereof
|
|
JP2000290291A
(ja)
|
1999-03-31 |
2000-10-17 |
Nippon Sanso Corp |
安定同位体標識オリゴヌクレオチド及びオリゴヌクレオチド検出方法
|
|
GB9916536D0
(en)
|
1999-07-14 |
1999-09-15 |
Scarista Limited |
Nutritional or pharmaceutical compositions
|
|
ITMI991894A1
(it)
|
1999-09-09 |
2001-03-09 |
Carlo Ghisalberti |
Acido linoleico coniugato e trigliceride nuovi metodi di sintesi e d'uso
|
|
JP3432778B2
(ja)
|
1999-11-19 |
2003-08-04 |
森澤 紳勝 |
活性酸素消去剤の濃縮液、その製造方法および活性酸素消去剤パウダー
|
|
GB9929897D0
(en)
|
1999-12-18 |
2000-02-09 |
Slabas Antoni R |
Improvements in or relating to conjugated fatty acids and related compounds
|
|
JP2001270832A
(ja)
|
2000-03-27 |
2001-10-02 |
Ito En Ltd |
網膜障害予防剤
|
|
GB2368339B
(en)
|
2000-10-26 |
2002-09-18 |
Yissum Res Dev Co |
Complex incorporating a plurality of antioxidants
|
|
US20040043013A1
(en)
|
2000-12-28 |
2004-03-04 |
Mccleary Edward Larry |
Metabolic uncoupling therapy
|
|
US20020198177A1
(en)
|
2001-05-30 |
2002-12-26 |
Horrobin David Frederick |
Coenzyme Q and EPA
|
|
GB0113348D0
(en)
|
2001-06-01 |
2001-07-25 |
Mars Uk Ltd |
Skin diet
|
|
WO2003035095A1
(en)
|
2001-10-19 |
2003-05-01 |
Maxim Pharmaceuticals, Inc. |
Use of histamine to treat liver disease
|
|
US6870077B2
(en)
|
2002-01-30 |
2005-03-22 |
Edward O. Kenaschuk |
High linolenic acid flax
|
|
US7582785B2
(en)
|
2002-04-01 |
2009-09-01 |
University Of Southern California |
Trihydroxy polyunsaturated eicosanoid derivatives
|
|
JP2004081156A
(ja)
|
2002-08-28 |
2004-03-18 |
Shigeo Ota |
糖尿病および糖尿病関連疾患の予測のためのマーカーおよび個体分類方法
|
|
EP1548116A4
(en)
|
2002-09-30 |
2006-04-05 |
Ajinomoto Kk |
PROCESS FOR PRODUCING A PROTEIN MARKED BY A STABLE ISOTOPE
|
|
US7795203B2
(en)
|
2002-09-30 |
2010-09-14 |
Babizhayev Mark A |
Method for topical treatment of eye disease and composition and device for said treatment
|
|
MXPA05005240A
(es)
|
2002-12-06 |
2005-07-25 |
Alcon Inc |
Imitadores de la superoxido - dismutasa para el tratamiento de desordenes y enfermedades oculares.
|
|
TW200413274A
(en)
|
2002-12-27 |
2004-08-01 |
Wako Pure Chem Ind Ltd |
Deuteration or tritiation method
|
|
KR20050029582A
(ko)
|
2003-09-23 |
2005-03-28 |
주식회사 리포젠 |
알지닌 공액리놀레인산 복합체를 포함하는 항산화 조성물
|
|
IL158552A0
(en)
|
2003-10-22 |
2004-05-12 |
Enzymotec Ltd |
Lipids containing omega-3 fatty acids
|
|
EP1713463A4
(en)
|
2004-01-19 |
2009-03-18 |
Martek Biosciences Corp |
REELIN LACK OR DYSFUNCTION AND RELEVANT PROCEDURE
|
|
US20050164908A1
(en)
|
2004-01-23 |
2005-07-28 |
Ginsberg Myron D. |
Neuroprotective complex for treatment of cerebral ischemia and injury
|
|
JP2008504372A
(ja)
|
2004-06-18 |
2008-02-14 |
ニューロケム （インターナショナル） リミティッド |
β−アミロイド関連疾患の治療のための治療用製剤
|
|
US20090232916A1
(en)
|
2004-08-09 |
2009-09-17 |
Avidor Shulman |
Food products for diabetics
|
|
JP2006053100A
(ja)
|
2004-08-13 |
2006-02-23 |
Institute Of Physical & Chemical Research |
動物の代謝解析方法、ラベル動物の製造方法、ラベル動物、および、動物のｎｍｒ測定方法
|
|
CA2588166A1
(en)
|
2004-11-19 |
2006-05-26 |
Martek Biosciences Corporation |
Oxylipins from long chain polyunsaturated fatty acids and methods of making and using the same
|
|
WO2006073147A1
(ja)
|
2005-01-04 |
2006-07-13 |
Mochida Pharmaceutical Co., Ltd. |
脂肪毒性の改善剤
|
|
US7250416B2
(en)
|
2005-03-11 |
2007-07-31 |
Supergen, Inc. |
Azacytosine analogs and derivatives
|
|
US20070004639A1
(en)
|
2005-07-01 |
2007-01-04 |
Bodybio, Inc. |
Methods and compositions for treating Parkinson's disease
|
|
KR20130101596A
(ko)
|
2005-07-08 |
2013-09-13 |
마텍 바이오싸이언스스 코포레이션 |
치매 및 치매-전단계와 관련된 용태의 치료를 위한 다중불포화 지방산
|
|
JP2009525948A
(ja)
|
2005-12-20 |
2009-07-16 |
シラメッド・インコーポレーテッド |
高親油性スルフヒドリル化合物の製薬組成物及び使用方法
|
|
EP1973536A2
(en)
|
2006-01-05 |
2008-10-01 |
Reliant Pharmaceuticals, Inc. |
Treatment of fatty liver
|
|
WO2007081910A2
(en)
|
2006-01-05 |
2007-07-19 |
Kinemed, Inc. |
Compositions and methods of treatment using modulators of motonueron diseases
|
|
JP5137168B2
(ja)
|
2006-02-27 |
2013-02-06 |
独立行政法人科学技術振興機構 |
安定同位体標識脂肪族アミノ酸、その標的蛋白質への組み込み方法並びに蛋白質のｎｍｒ構造解析方法
|
|
GB0604647D0
(en)
|
2006-03-08 |
2006-04-19 |
Shchepinov Mikhail |
Stabilized food supplements and their derivatives
|
|
WO2008143642A2
(en)
|
2006-11-09 |
2008-11-27 |
Children's Medical Center Corporation |
Methods of treating and preventing ocular neovascularization with omega-3 polyunsaturated fatty acids
|
|
US8524695B2
(en)
|
2006-12-14 |
2013-09-03 |
Knopp Neurosciences, Inc. |
Modified release formulations of (6R)-4,5,6,7-tetrahydro-N6-propyl-2,6-benzothiazole-diamine and methods of using the same
|
|
EP1961311A1
(en)
|
2007-02-23 |
2008-08-27 |
Belovo S.A., Egg Science & Technology |
Food comprising polyunsaturated fatty acids for the prevention of chronic diseases
|
|
CN101677564A
(zh)
|
2007-03-14 |
2010-03-24 |
诺普神经科学股份有限公司 |
(6r)-4,5,6,7-四氢-n6-丙基-2,6-苯并噻唑-二胺的改良释放制剂及其使用方法
|
|
US20080234197A1
(en)
|
2007-03-19 |
2008-09-25 |
Undurti N Das |
Method(s) of stabilizing and potentiating the actions and administration of brain-derived neurotrophic factor (BDNF)
|
|
WO2008146721A1
(ja)
|
2007-05-25 |
2008-12-04 |
Santen Pharmaceutical Co., Ltd. |
加齢黄斑変性の予防又は治療剤
|
|
US8501032B2
(en)
*
|
2007-07-26 |
2013-08-06 |
San Diego State University (Sdsu) Foundation |
Catalysts for alkene isomerization and conjugating double bonds in polyunsaturated fats and oils
|
|
CA2693310C
(en)
|
2007-08-02 |
2018-11-27 |
Arresto Biosciences, Inc. |
Lox and loxl2 inhibitors, antibodies and uses thereof
|
|
US20090069354A1
(en)
|
2007-09-12 |
2009-03-12 |
Protia, Llc |
Deuterium-enriched gemcitabine
|
|
KR20100100818A
(ko)
|
2007-10-31 |
2010-09-15 |
프로노바 바이오파마 노르지 에이에스 |
새로운 ｄｈａ 유도체 및 약물로서 그들의 사용
|
|
US8021874B2
(en)
|
2008-01-28 |
2011-09-20 |
The Board Of Regents Of The University Of Oklahoma |
Very long chain polyunsaturated fatty acids, methods of production, and uses
|
|
DK2268604T3
(en)
|
2008-03-14 |
2017-03-27 |
Retrotope Inc |
CANCER THERAPIES BY USING ISOTO-SUBSTITUTED LYSIN
|
|
US8637486B2
(en)
|
2008-03-14 |
2014-01-28 |
Retrotope, Inc. |
Therapeutic substances that modulate genome methylation
|
|
EP2110027A1
(en)
|
2008-04-01 |
2009-10-21 |
Nestec S.A. |
Long-chain polyunsaturated fatty acids (LC-PUFA) in maternal nutrition during pregnancy and lactation
|
|
CN102056907B
(zh)
|
2008-04-04 |
2014-12-31 |
武田药品工业株式会社 |
杂环衍生物及其用途
|
|
DK2280928T3
(en)
|
2008-05-01 |
2018-11-05 |
Complexa Inc |
Vinyl-substituted fatty acids
|
|
JPWO2009151125A1
(ja)
|
2008-06-13 |
2011-11-17 |
持田製薬株式会社 |
肝障害の診断及び治療
|
|
GB0813599D0
(en)
|
2008-07-24 |
2008-09-03 |
Pharma Marine As |
Method
|
|
EP3403650A3
(en)
|
2008-07-28 |
2019-02-13 |
Blanchette Rockefeller Neurosciences, Institute |
Pkc-activating compounds for the treatment of neurodegenerative diseases
|
|
JP5030175B2
(ja)
|
2008-09-11 |
2012-09-19 |
独立行政法人産業技術総合研究所 |
重水素化化合物製造用触媒及びそれを用いた重水素化化合物の製造方法
|
|
EP2375900B1
(en)
|
2008-12-11 |
2016-03-02 |
Biovista, Inc. |
Methods for treating multiple sclerosis using tetracyclic pyrazinoindoles
|
|
ES2345241B1
(es)
|
2009-03-16 |
2011-09-08 |
Lipopharma Therapeutics |
Uso de 2-hidroxiderivados de acidos grasos poliinsaturados como medicamentos.
|
|
US20120046363A1
(en)
|
2009-05-11 |
2012-02-23 |
University Of Maryland, Baltimore |
Docosahexaenoic acid for the treatment of heart failure
|
|
WO2010143053A1
(en)
|
2009-06-10 |
2010-12-16 |
Energy4Life Ag |
Methods and compositions for treating insulin resistance, diabetes mellitus type 2, metabolic syndrome and related disorders
|
|
WO2011041639A2
(en)
|
2009-10-02 |
2011-04-07 |
Miller Raymond A |
Heteroatom containing substituted fatty acids
|
|
DK2493296T3
(en)
|
2009-10-30 |
2019-04-15 |
Retrotope Inc |
REMOVAL OF OXIDATIVE STRESS STATES WITH PUFA DERIVATIVES
|
|
WO2011097273A1
(en)
|
2010-02-02 |
2011-08-11 |
Martek Biosciences Corporation |
Methods and compositions for treating non-alcoholic fatty liver disease with docosahexaenoic acid and n-acetyl lcystenine
|
|
JP5896472B2
(ja)
|
2010-11-16 |
2016-03-30 |
株式会社 西崎創薬研究所 |
ＰＫＣ−ε活性化剤
|
|
US10154983B2
(en)
|
2011-04-26 |
2018-12-18 |
Retrotope, Inc. |
Neurodegenerative disorders and muscle diseases implicating PUFAs
|
|
WO2012148929A2
(en)
|
2011-04-26 |
2012-11-01 |
Retrotope, Inc. |
Disorders implicating pufa oxidation
|
|
KR102020579B1
(ko)
|
2011-04-26 |
2019-09-10 |
레트로토프 인코포레이티드 |
에너지 프로세싱 손상 장애 및 미토콘드리아 결함
|
|
US10058522B2
(en)
|
2011-04-26 |
2018-08-28 |
Retrotope, Inc. |
Oxidative retinal diseases
|
|
WO2012174262A2
(en)
|
2011-06-14 |
2012-12-20 |
Cenestra Llc |
Formulations and methods of treating subjects having central nervous system, endocrine, inflammatory or cardiovascular disorders or at-risk thereof with highly purified omega-3 fatty acid formulations
|
|
AU2015229240B9
(en)
*
|
2014-03-13 |
2019-05-02 |
Biojiva Llc |
Optic neuropathy treatment and reduction of steroid-induced oxidative stress with stabilized polyunsaturated substances
|
|
WO2015162265A1
(en)
|
2014-04-24 |
2015-10-29 |
Institut National De La Sante Et De La Recherche Medicale (Inserm) |
New lipophenol compounds and uses thereof
|
|
WO2017091279A1
(en)
*
|
2015-11-23 |
2017-06-01 |
Retrotope, Inc. |
Site-specific isotopic labeling of 1, 4-diene systems
|
|
CN107569684B
(zh)
|
2016-07-05 |
2021-04-09 |
杰尼视界公司 |
生发配方
|
|
CA3056882A1
(en)
*
|
2017-03-20 |
2018-09-27 |
University Of Southern California |
Very-long-chain polyunsaturated fatty acids, elovanoid hydroxylated derivatives, and methods of use
|
|
EP4107163A4
(en)
|
2020-02-21 |
2024-06-19 |
Retrotope, Inc. |
PROCESSES FOR ISOTOPIC MODIFICATION OF POLYUNSATURATED FATTY ACIDS AND THEIR DERIVATIVES
|